3/19/19 21:01 | 3/18/19 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | S | -180 | 15.51 | 0 | -12 | -7 | 152 | D | | | | | | | | | | | | | | |
2/20/19 21:31 | 2/19/19 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | S | -96 | 17.68 | 0 | -5 | -3 | 169 | D | | | | | | | | | | | | | | |
3/16/18 20:03 | 3/15/18 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | S.dm | -204 | 31.64 | 0 | -6 | -4 | 142 | D | | | | | | | | | | | | | | |
3/16/18 20:03 | 3/16/18 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | M.d | 51 | 2.55 | 0 | 20 | 16 | 142 | D | | | | | | | | | | | | | | |
3/9/18 20:36 | 3/7/18 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | S | -858 | 31.43 | 0 | -27 | -17 | 132 | D | | | | | | | | | | | | | | |
11/24/17 16:06 | 11/22/17 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | S | -190 | 24.94 | 0 | -8 | -5 | 134 | D | | | | | | | | | | | | | | |
10/20/17 20:10 | 10/18/17 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | S | -200 | 26.16 | 0 | -8 | -5 | 141 | D | | | | | | | | | | | | | | |
9/22/17 20:08 | 9/20/17 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | S | -179 | 23.58 | 0 | -8 | -5 | 149 | D | | | | | | | | | | | | | | |
8/25/17 19:41 | 8/23/17 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | M.d | 1 | 2.55 | 0 | 0 | 0 | 156 | D | | | | | | | | | | | | | | |
8/25/17 19:41 | 8/23/17 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | S.d | -519 | 22.76 | 0 | -23 | -13 | 156 | D | | | | | | | | | | | | | | |
6/14/17 20:11 | 6/12/17 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | M.d | 21 | 2.55 | 0 | 8 | 5 | 178 | D | | | | | | | | | | | | | | |
5/31/17 21:38 | 5/30/17 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | M.d | 13 | 2.55 | 0 | 5 | 3 | 170 | D | | | | | | | | | | | | | | |
5/24/17 21:13 | 5/22/17 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | S.m | -649 | 20.29 | 0 | -32 | -16 | 165 | D | | | | | | | | | | | | | | |
2/24/17 21:04 | 2/22/17 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | S | -227 | 20.57 | 3 | -11 | -5 | 200 | D | 25 | 7 | 28 | 8 | -13 | -6 | -4 | -5 | 4 | -2 | -3 | | | |
1/27/17 20:04 | 1/25/17 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | S | -237 | 19.78 | 3 | -12 | -6 | 185 | D | 17 | -10 | 39 | 32 | 18 | -17 | -4 | -3 | -4 | 6 | 6 | 17 | | |
12/30/16 18:38 | 12/28/16 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | S | -251 | 20.94 | 4 | -12 | -6 | 196 | D | 26 | -41 | 54 | 32 | 11 | 22 | 9 | -3 | 4 | 13 | -3 | 0 | | |
11/25/16 21:32 | 11/25/16 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | S | -215 | 17.92 | 4 | -12 | -5 | 208 | D | 10 | -50 | -5 | 30 | 23 | 48 | 0 | 3 | -2 | -5 | 20 | 17 | | |
10/28/16 21:29 | 10/26/16 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | S | -178 | 14.85 | 2 | -12 | -5 | 220 | D | -23 | -44 | -19 | 11 | -11 | -6 | 2 | 1 | -9 | -14 | 20 | 31 | 49 | |
1/4/16 21:10 | 12/30/15 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | M.d | 31 | 2.55 | 12 | 12 | 6 | 219 | D | | 102 | 9 | 12 | -13 | -6 | -7 | -3 | 1 | -15 | -38 | -43 | -58 | -37 |
12/1/14 21:26 | 11/28/14 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Browne L Daniel | CA | DO | CEO,P | P | 100 | 16.67 | 4 | 6 | 4 | 174 | D | | | -45 | -30 | -6 | -17 | 2 | -3 | 6 | 8 | 4 | -6 | 61 | 139 |